Let’s get phygital 2021: transforming from biotech to biopharma

Transforming from biotech to biopharma: creating a new value chain to serve unmet patient needs.

Discover how Galapagos’ supply chain acted as the backbone of their transformation from a biotech to a biopharma company.

By Wouter Keymeulen, VP Quality Galapagos, and Pieter Van den Meutter, Head of Customer Intelligence Bluecrux.

Watch now for free!

Featured speakers

  • Pieter van den Meutter
    Pieter Van den Meutter
    Head of Customer, Bluecrux
  • Wouter Keymolen
    Wouter Keymeulen
    VP Quality, Galapagos